HCM
Hutchison China MediTech

488
Mkt Cap
$2.42B
Volume
27,238.00
52W High
$19.50
52W Low
$11.51
PE Ratio
5.28
HCM Fundamentals
Price
$13.85
Prev Close
$13.85
Open
$13.70
50D MA
$14.64
Beta
1.01
Avg. Volume
25,743.38
EPS (Annual)
$2.62
P/B
1.95
Rev/Employee
$306,215.29
$1,071.08
Loading...
Loading...
Poll

Earnings Recap

HUTCHMED reported consolidated revenue of $548.5M and net income attributable to the company of $456.9M for 2025, resulting in basic earnings per share of $0.53.

Bullish

HUTCHMED advanced its pipeline with a new ATTC platform and secured key regulatory approvals for fruquintinib in 38 countries and savolitinib in China, driving commercial growth.

Bearish

HUTCHMED faces significant operational risks from PRC government influence and potential U.S. delisting under HFCAA, compounded by reduced equity earnings from a recent divestment.

Latest HCM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.